Study doses · No personal directions
How was Thymosin Alpha-1 given in studies?
You’ll see how much people got, which illnesses they had, and where each shot went.
What do the study doses tell you?
Goldstein’s group first found Thymosin Alpha-1 in calf thymus. They hoped to learn how that gland guides your immune cells. Later trials gave the compound as shots under the skin. This page tells you what those trials did.
The most common plan used 1.6 milligrams twice a week [4]. Other one-time doses ran from 0.8 to 6.4 milligrams [4]. Those amounts belong to studies. They aren’t a plan for you.
After a shot, half the amount in blood was gone in about two hours. Doctors call that span the half-life. Blood levels moved near their starting point within about a day. Think of water draining from a small bucket. You won’t find personal directions here.
Which thymosin alpha 1 dosage plans did studies test?
These plans belonged to set groups in studies. They don’t tell you what to take. The most common thymosin alpha 1 dosage was 1.6 mg under the skin twice weekly. Doctors used that plan for long-term hepatitis [4].
A large review found one-time doses from 0.8–6.4 mg. It also found repeated plans of 1.6–16 mg over five to seven days [4]. The ETASS and TESTS sepsis trials used 1.6 mg under the skin every 12 hours. That plan lasted five to seven days [2][3]. COVID-19 record reviews used 1.6 mg under the skin each day [6].
Each number tells you what one study group received. The numbers don’t set a safe plan for you.
Where did each thymosin alpha 1 injection go?
Human trials put each thymosin alpha 1 injection under the skin. The shot went into the fat layer, not a vein. Doctors call that an under-the-skin shot.
Cell studies and mouse studies gave the compound in other ways [5]. Those methods don’t tell you what happens after a human shot. The drug came as dry powder that had to be mixed [4]. This page doesn’t teach mixing or shot care.
How long did the compound stay in the blood?
Researchers first measured the timing in healthy volunteers. After a shot under the skin, Thymosin Alpha-1 reached its highest blood level in one to two hours. About half was gone two hours later. Blood levels moved near their starting point within about 24 hours.
You can see that blood didn’t hold onto much of the compound [4]. Its short stay helps explain why studies repeated the shots. Short sepsis studies sometimes used them every 12 hours. Long-term hepatitis studies used twice-weekly plans. Those facts still don’t set a plan for you.
Why can’t these study doses set your dose?
Every plan above came from a trial or approved use abroad. The United States hasn’t approved Thymosin Alpha-1 for sale. Researchers chose set groups with set illnesses [4].
You can’t carry their dose numbers into your own care. A vial sold outside drug rules brings its own risk. This page reports what researchers gave. It doesn’t tell you what to take.